MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-14-2022
CASI Pharmaceuticals Total Inventories 2011-2026 | CASI
Annual Total Inventories CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.91 M | 1.36 M | 4.54 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.54 M | 1.36 M | 2.6 M |
Quarterly Total Inventories CASI Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 5.77 M | 5.79 M | 3.72 M | 1.91 M | 1.73 M | 3.48 M | 2.99 M | 1.36 M | 1.36 M | 1.36 M | 1.36 M | 4.54 M | 4.54 M | 4.54 M | 4.54 M | 283 K | 283 K | 283 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.79 M | 283 K | 2.77 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
39.1 K | $ 1.06 | -0.93 % | $ 5.78 M |  China |
 |
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.82 | -4.85 % | $ 464 M |  Britain |
 |
Biogen
BIIB
|
2.46 B | $ 187.4 | 0.75 % | $ 27.3 B |  USA |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
BioXcel Therapeutics
BTAI
|
679 K | $ 1.98 | -1.0 % | $ 5.02 M | USA |
 |
Catalyst Biosciences
CBIO
|
4.28 M | $ 10.74 | -2.1 % | $ 707 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
154 M | $ 27.75 | 0.02 % | $ 1.34 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
80.6 M | $ 11.13 | -2.02 % | $ 720 M | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
Axon Enterprise
AXON
|
265 M | $ 633.45 | 3.34 % | $ 48 B | USA |
 |
Aytu BioScience
AYTU
|
11.4 M | $ 2.64 | -0.75 % | $ 16.6 M | USA |
 |
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B |  Cayman-islands |